Q3 2014

Filed Jan 8, 2015 · 10-Q · 100 days after period end · 0001513160-15-000011

Q3 2014 · 10-Q

Revenue

$3.00K

−98.4% vs Q3 2013

Net Income

-$4.22M

N/M vs Q3 2013

EPS Diluted

-$0.01

— vs Q3 2013

Gross Profit-$2,000N/M

Operating Income

Same quarter

Metric	Q3 2014	Q3 2013	Q3 2012	Q3 2011
Revenue	$3.00K	$183.00K	$120.00K	$2.00K
Net Income	-$4.22M	-$319.00K	-$1.40M	$23.00K
EPS Diluted	-$0.01	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR